Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat

Rodney W Roosevelt, Douglas C Smith, Richard W Clough, Robert A Jensen, Ronald A Browning, Rodney W Roosevelt, Douglas C Smith, Richard W Clough, Robert A Jensen, Ronald A Browning

Abstract

The vagus nerve is an important source of afferent information about visceral states and it provides input to the locus coeruleus (LC), the major source of norepinephrine (NE) in the brain. It has been suggested that the effects of electrical stimulation of the vagus nerve on learning and memory, mood, seizure suppression, and recovery of function following brain damage are mediated, in part, by the release of brain NE. The hypothesis that left vagus nerve stimulation (VNS) at the cervical level results in increased extracellular NE concentrations in the cortex and hippocampus was tested at four stimulus intensities: 0.0, 0.25, 0.5, and 1.0 mA. Stimulation at 0.0 and 0.25 mA had no effect on NE concentrations, while the 0.5 mA stimulation increased NE concentrations significantly in the hippocampus (23%), but not the cortex. However, 1.0 mA stimulation significantly increased NE concentrations in both the cortex (39%) and hippocampus (28%) bilaterally. The increases in NE were transient and confined to the stimulation periods. VNS did not alter NE concentrations in either structure during the inter-stimulation baseline periods. No differences were observed between NE levels in the initial baseline and the post-stimulation baselines. These findings support the hypothesis that VNS increases extracellular NE concentrations in both the hippocampus and cortex.

Figures

Figure 1
Figure 1
Effect of various intensities of VNS on extracellular NE in the hippocampus of freely moving rats, shown as percent change from baseline levels. The 0.5 and 1.0mA differed significantly from basal levels (* p

Figure 2

Effect of various intensities of…

Figure 2

Effect of various intensities of VNS on extracellular NE in the cortex of…

Figure 2
Effect of various intensities of VNS on extracellular NE in the cortex of freely moving rats, shown as percent change from baseline levels. The 1.0mA differed significantly from basal levels (* p

Figure 3

Increased extracellular NE concentrations in…

Figure 3

Increased extracellular NE concentrations in ipsilateral and contralateral cerebral cortex following left vagus…

Figure 3
Increased extracellular NE concentrations in ipsilateral and contralateral cerebral cortex following left vagus nerve stimulation. These increases in extracellular NE did not differ significantly on the basis of hemisphere (p=0.49, N=6). Average baseline NE concentration in ipsilateral dialysate was 0.135 ± 0.012 pg/μL and in the contralateral dialysate was 0.095 ± 0.017 pg/μL.

Figure 4

Panel A .: Changes in…

Figure 4

Panel A .: Changes in extracellular NE concentration in the hippocampus of one…
Figure 4
Panel A.: Changes in extracellular NE concentration in the hippocampus of one rat during alternating 1h periods of dialysate collection for baseline (stimulus off) and stimulation (VNS at 0.5 mA). Panel B: Change in extracellular NE concentration in the cortex of a rat during 1h periods of dialysate collection for baseline (stimulus off) and stimulation (VNS at 1.0 mA). Depicts actual concentration of NE (pg/μL) measured in each sample rather than percent change. Note that the NE concentration returns to baseline when vagus nerve is not being stimulated.

Figure 5

Representative histological sections showing location…

Figure 5

Representative histological sections showing location of microdialysis probes in: (A) cortex and (B)…

Figure 5
Representative histological sections showing location of microdialysis probes in: (A) cortex and (B) hippocampus. Arrows indicate location of dialysis membrane.
Similar articles
Cited by
References
    1. Amar AP, Levy ML, Mc Comb JG, Apuzzo ML. Vagus nerve stimulation for control of intractable seizures in childhood. Pediatric Neurosurg. 2001;34:218–223. - PubMed
    1. Armitage R, Husain M, Hoffman R, Rush AJ. The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. J Psychosom Res. 2003;54:475–482. - PubMed
    1. Ben-Menachem E. Modern management of epilepsy: Vagus nerve stimulation. Baillieres Clin Neurol. 1996;5:841–848. - PubMed
    1. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1:477–482. - PubMed
    1. Bolwig TG. Putative common pathways in therapeutic brain stimulation for affective disorders. CNS Spectr. 2003;8:490–495. - PubMed
Show all 83 references
Publication types
MeSH terms
LinkOut - more resources
[x]
Cite
Copy Download .nbib .nbib
Format: AMA APA MLA NLM
Figure 2
Figure 2
Effect of various intensities of VNS on extracellular NE in the cortex of freely moving rats, shown as percent change from baseline levels. The 1.0mA differed significantly from basal levels (* p

Figure 3

Increased extracellular NE concentrations in…

Figure 3

Increased extracellular NE concentrations in ipsilateral and contralateral cerebral cortex following left vagus…

Figure 3
Increased extracellular NE concentrations in ipsilateral and contralateral cerebral cortex following left vagus nerve stimulation. These increases in extracellular NE did not differ significantly on the basis of hemisphere (p=0.49, N=6). Average baseline NE concentration in ipsilateral dialysate was 0.135 ± 0.012 pg/μL and in the contralateral dialysate was 0.095 ± 0.017 pg/μL.

Figure 4

Panel A .: Changes in…

Figure 4

Panel A .: Changes in extracellular NE concentration in the hippocampus of one…
Figure 4
Panel A.: Changes in extracellular NE concentration in the hippocampus of one rat during alternating 1h periods of dialysate collection for baseline (stimulus off) and stimulation (VNS at 0.5 mA). Panel B: Change in extracellular NE concentration in the cortex of a rat during 1h periods of dialysate collection for baseline (stimulus off) and stimulation (VNS at 1.0 mA). Depicts actual concentration of NE (pg/μL) measured in each sample rather than percent change. Note that the NE concentration returns to baseline when vagus nerve is not being stimulated.

Figure 5

Representative histological sections showing location…

Figure 5

Representative histological sections showing location of microdialysis probes in: (A) cortex and (B)…

Figure 5
Representative histological sections showing location of microdialysis probes in: (A) cortex and (B) hippocampus. Arrows indicate location of dialysis membrane.
Figure 3
Figure 3
Increased extracellular NE concentrations in ipsilateral and contralateral cerebral cortex following left vagus nerve stimulation. These increases in extracellular NE did not differ significantly on the basis of hemisphere (p=0.49, N=6). Average baseline NE concentration in ipsilateral dialysate was 0.135 ± 0.012 pg/μL and in the contralateral dialysate was 0.095 ± 0.017 pg/μL.
Figure 4
Figure 4
Panel A.: Changes in extracellular NE concentration in the hippocampus of one rat during alternating 1h periods of dialysate collection for baseline (stimulus off) and stimulation (VNS at 0.5 mA). Panel B: Change in extracellular NE concentration in the cortex of a rat during 1h periods of dialysate collection for baseline (stimulus off) and stimulation (VNS at 1.0 mA). Depicts actual concentration of NE (pg/μL) measured in each sample rather than percent change. Note that the NE concentration returns to baseline when vagus nerve is not being stimulated.
Figure 5
Figure 5
Representative histological sections showing location of microdialysis probes in: (A) cortex and (B) hippocampus. Arrows indicate location of dialysis membrane.

References

    1. Amar AP, Levy ML, Mc Comb JG, Apuzzo ML. Vagus nerve stimulation for control of intractable seizures in childhood. Pediatric Neurosurg. 2001;34:218–223.
    1. Armitage R, Husain M, Hoffman R, Rush AJ. The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. J Psychosom Res. 2003;54:475–482.
    1. Ben-Menachem E. Modern management of epilepsy: Vagus nerve stimulation. Baillieres Clin Neurol. 1996;5:841–848.
    1. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002;1:477–482.
    1. Bolwig TG. Putative common pathways in therapeutic brain stimulation for affective disorders. CNS Spectr. 2003;8:490–495.
    1. Boon P, Vonck K, de Reuck J, Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure. 2002;11(Suppl A):448–455.
    1. Boyeson MG. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211–1214.
    1. Boyeson MG, Feeney DM. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem behav. 1990;35:497–501.
    1. Boyeson MG, Krobert KA. Cerebellar norepinephrine infusions facilitate recovery after sensorimotor cortex injury. Brain res bull. 1992;29:435–439.
    1. Carpenter LL, Friehs GM, Price LH. Cervical vagus nerve stimulation for treatment-resistant depression. Neurosurg Clin N Am. 2003;14:275–282.
    1. Chavel SM, Westerveld M, Spencer S. Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy Behav. 2003;4:302–309.
    1. Clark KB, Krahl SE, Smith DC, Jensen RA. Post-training unilateral vagal stimulation enhances retention performance in the rat. Neurobiol Learn Mem. 1995;63:213–216.
    1. Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci. 1999;2:94–98.
    1. Clark KB, Smith DC, Hassert DL, Browning RA, Naritoku DK, Jensen RA. Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes in the rat. Neurobiol Learn Mem. 1998;70:364–373.
    1. Crumrine PK. Vagal nerve stimulation in children. Semin Pediatr Neurol. 2000;7:216–223.
    1. DeGiorgio CM, Schachter SC, Handforth A, Salinsky M, Thompson J, Uthman B, Reed R, Collins S, Tecoma E, Morris GL, Vaughn B, Naritoku DK, Henry T, Labar D, Gilmartin R, Labiner D, Osorio I, Ristanovic R, Jones J, Murphy J, Ney G, Wheless J, Lewis P, Heck C. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 2000;41:1195–1200.
    1. Dunn-Meynell A, Pan S, Levin BE. Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h. Brain Res. 1994;660:88–95.
    1. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 2000;42:203–210.
    1. Feeney DM, Gonzales A, Law WA. Amphetamine restores locomotor function after motor cortex injury in the rat. Proc West Pharmacol Soc. 1981;24:15–17.
    1. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855–857.
    1. Feeney DM, Hovda DA. Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology (Berl) 1983;79:67–71.
    1. Feeney DM, Weisend MP, Kline AE. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast. 1993;4:199–213.
    1. Fernandez-Guardiola A, Martinez A, Valdes-Cruz A, Magdaleno-Madrigal VM, Martinez D, Fernandez-Mas R. Vagus nerve prolonged stimulation in cats: effects on epileptogenesis (amygdala electrical kindling): behavioral and electrographic changes. Epilepsia. 1999;40:822–829.
    1. George MS, Sackeim HA, Marangell LB, Husain MM, Nahas Z, Lisanby SH, Ballenger JC, Rush AJ. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am. 2000;23:757–783.
    1. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol. Psychiatry. 2005;58:364–373.
    1. Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain research. 1990;508:305–309.
    1. Groves DA, Bowman EM, Brown VJ. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci lett. 2005;379:174–179.
    1. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL, 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW. Vagus nerve stimulation therapy for partial -onset seizures. A randomized active-control trial. Neurology. 1998;51:48–55.
    1. Harden CL, Pulver MC, Ravdin LD. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000;1:93–99.
    1. Hassert DL, Miyashita T, Williams CL. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav Neurosci. 2004;118:79–88.
    1. Henry TR, Bakay RA, Pennell PB, Epstein CM, Votaw JR. Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects at high and low levels of stimulation. Epilepsia. 2004;45:1064–1070.
    1. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology. 2002;59(Suppl 4):S3–S14.
    1. Henry TR, Bakay RA, Votaw JR, Pennell PB, Epstein CM, FaberTLGrafton ST. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia. 1998;39:983–990.
    1. Holmes MD, Silbergeld DL, Drouhard D, Wilensky AJ, Ojemann LM. Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes. Seizure. 2004;13:340–345.
    1. Hoppe C, Helmstaedter C, Scherrmann J, Elger CE. Self-Reported Mood Changes following 6 Months of Vagus Nerve Stimulation in Epilepsy Patients. Epilepsy Behav. 2001;2:335–342.
    1. Hovda DA, Sutton RL, Feeney DM. Recovery of tactile placing after visual cortex ablation in cat: a behavioral and metabolic study of diaschisis. Exp Neurol. 1987;97:391–402.
    1. Hovda DA, Sutton RL, Feeney DM. Amphetamine-induced recovery of visual cliff performance after bilateral visual cortex ablation in cats: measurements of depth perception thresholds. Behav Neurosci. 1989;103:574–584.
    1. Huf RL, Mamelak A, Kneedy-Cayem K. Vagus nerve stimulation therapy: 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities. Epilepsy Behavior. 2005;6:417–423.
    1. Hui AC, Lam JM, Wong KS, Kay R, Poon WS. Vagus nerve stimulation for refractory epilepsy: long term efficacy and side-effects. Chin Med J (Engl) 2004;117:58–61.
    1. Kikuchi K, Nishino K, Ohyu H. L-DOPS-Accelerated recovery of locomotor function in rats subjected to sensorimotor cortex ablation injury: pharmacobehavioral studies. Tohoku J Exp Med. 1999;188:203–215.
    1. Kikuchi K, Nishino K, Ohyu H. Increasing CNS norepinephrine levels by the precursor L-DOPS facilitate beam-walking recovery after sensorimotor cortex ablation in rats. Brain Res. 2000;860:130–135.
    1. Kossoff EH, Pyzik PL. Improvement in alertness and behavior in children treated with combination topiramate and vagus nerve stimulation. Epilepsy Behav. 2004;5:256–259.
    1. Koszewski W, Bacia T, Rysz A. Vagus nerve stimulation (VNS) in the treatment of drug-resistant epilepsy. A 4-year follow-up evaluation of VNS treatment efficacy. Neurol Neurochir Pol. 2003;37:573–586.
    1. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia. 1998;39:709–714.
    1. Krahl SE, Senanayake SS, Handforth A. Right-sided vagus nerve stimulation reduces generalized seizure severity in rats as effectively as left-sided. Epilepsy Res. 2003;56:1–4.
    1. Krahl SE, Senanayake SS, Pekary AE, Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res. 2004;38:237–240.
    1. Krobert KA, Sutton RL, Feeny DM. Spontaneous and amphetamine-evoked release of cerebellar noradrenaline after sensorimotor cortex contusion: an in vivo microdialysis study in the awake rat. J Neurochem. 1994;62:2233–2240.
    1. Leonard BE. The role of noradrenaline in depression: a review. J Psychopharmacol. 1997;11:S39–47.
    1. Levin BE, Brown KL, Pawer G, Dunn-Meynell A. Widespread and lateralization effects of acute traumatic brain injury on norepinephrine turnover in the rat brain. Brain Res. 1995;674:307–313.
    1. Loughlin SE, Foote KL, Fallon JH. Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res Bull. 1982;9:287–294.
    1. Loughlin SE, Foote SL, Grzanna R. Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets. Neuroscience. 1986;18:307–319.
    1. Loy R, Koziell DA, Lindsey JD, Moore RY. Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol. 1980;189:699–710.
    1. Macritchie KA, Young AH. Emerging targets for the treatment of depressive disorder. Expert Opin Ther Targets. 2001;5:601–612.
    1. Mc Gaugh JL. Memory-accenting of consolidation. Science. 2000;287:248–251.
    1. Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002;51:280–287.
    1. McIntosh TK, Yu T, Gennarelli TA. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem. 1994;63:1426–1433.
    1. Meyer P, Horel J, Meyer D. Effects of dl-amphetamine upon placing responses in neodecorticate cats. J Comp Physiol Psych. 1963;56:402–404.
    1. Michael JE, Wegener K, Barnes DW. Vagus nerve stimulation for intractable seizures: one year follow-up. J Neurosci Nurs. 1993;25:362–6.
    1. Moore RY, Card JP. Noradrenaline-containing neuron systems. In: Bjèorklund A, Hèokfelt T, Kuhar MJ, editors. Handbook of Chemical Neuroanatomy: Classical Transmitters in the CNS Part I. Elsievier; 1984.
    1. Morris GL, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology. 1999;53:1731–1735.
    1. Nagarajan L, Walsh P, Gregory P, Lee M. VNS therapy in clinical practice in children with refractory epilepsy. Acta Neurol Scand. 2002;105:13–17.
    1. Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 1995;22:53–62.
    1. Nielson KA, Jensen RA. Beta-adrenergic receptor agonist antihypertensive medications impair arousal-induced modulation of working memory in elderly humans. Behav Neural Biol. 1995;62:190–200.
    1. Nielson KA, Radtke RC, Jensen RA. Arousal-induced modulation of memory storage processes in humans. Neurobiology of Learning and Memory. 1996;66:133–142.
    1. Prasad MR, Tzigaret CM, Smith D, Soares H, McIntosh TK. Decreased alpha 1-adrenergic receptors after experimental brain injury. J Neurotrauma. 1992;9:269–279.
    1. Queen SA, Chen MJ, Feeney DM. d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats. Brain Res. 1997;777:42–50.
    1. Ramsey RE, Uthman BM, Augustinsson LE, Upton ARM, Naritoku D, Willis J, Treig T, Barolat G, Wernicke JF. 1994. Vagus nerve stimulation for treatment of partial seizures. 2. Safety, side effects and tolerability. Epilepsia. 1994;35:627–636.
    1. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, Nahas Z, Haines S, Simpson RK, Jr, Goodman R. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000;47:276–286.
    1. Saper CB, Kibbe MR, Hurley KM, Spencer S, Holmes HR, Leahy KM, Needleman P. Brain natriuretic peptide-like immunoreactive innervation of the cardiovascular and cerebrovascular systems in the rat. Circ Res. 1990;67:1345–1354.
    1. Sirven JI, Sperling M, Naritoku D, Schachter S, Labar D, Holmes M, Wilensky A, Cibula J, Labiner DM, Bergen D, Ristanovic R, Harvey J, Dasheiff R, Morris GL, O'Donovan CA, Ojemann L, Scales D, Nadkarni M, Richards B, Sanchez JD. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology. 2000;54:1179–1182.
    1. Smith DC, Modglin A, Roosevelt RW, Neese S, Jensen RA, Browning RA, Clough RW. Electrical stimulation of the vagus nerve enhances cognitive and motor recovery following moderate fluid percussion injury in the rat. J Neurotrauma. 2005;22:1485–1502.
    1. Stanton PK, Sarver JM. Norepinephrine regulates long-term potentiation of both the population spike and dendritic EPSP in hippocampal dentate gyrus. Brain Res Bull. 1987;18:115–119.
    1. Takaya M, Terry WJ, Naritoku DK. Vagus nerve stimulation induces a sustained anticonvulsant effect. Epilepsia. 1996;37:1111–1116.
    1. Takigawa M, Mogenson GJ. A study of inputs to antidromically identified neurons of the locus coeruleus. Brain Res. 1977;135:217–230.
    1. Tanganelli P, Ferrero S, Colotto P, Regesta G. Vagus nerve stimulation for treatment of medically intractable seizures. Evaluation of long-term outcome. Clin Neurol Neurosurg. 2002;105:9–13.
    1. Topfer LA, Hailey D. Vagus nerve stimulation (VNS) for treatment-resistant depression. Issues Emerg Health Technol. 2001;25:1–4.
    1. Uthman BM, Wilder BJ, Penry JK, Dean C, Ramsay RE, Reid SA, Hammond EJ, Tarver WB, Wernicke JF. Treatment of epilepsy by stimulation of the vagus nerve. Neurology. 1993;43:1338–1345.
    1. Van Bockstaele, E. J., Peoples, J., Telegan, P., 1999. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J. Comp Neurol. 412, 410–428.
    1. Wakai S, Kotagal P. Vagus nerve stimulation for children and adolescents with intractable epilepsies. Pediatr Int. 2001;43:61–65.
    1. Wheless JW, Baumgartner J. Vagus nerve stimulation therapy. Drugs Today (Barc) 2004;40:501–515.
    1. Williams CL, McGaugh JL. Reversible lesions of the nucleus of the solitary tract attenuate the memory-modulating effects of posttraining epinephrine. Behav Neurosci. 1993;107:955–962.
    1. Woodbury DM, Woodbury JW. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia. 1990;31(Suppl 2):S7–19.
    1. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992;33:1005–1012.

Source: PubMed

3
Sottoscrivi